The Full Wiki

More info on Saredutant

Saredutant: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Saredutant
Systematic (IUPAC) name
N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)- 2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
Identifiers
CAS number 142001-63-6
ATC code none
PubChem 104974
Chemical data
Formula C 31H35Cl2N3O2  
Mol. mass 552.5345 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Saredutant (SR 48968) is a psychoactive drug and research chemical that has antidepressant, anxiolytic, and antiemetic properties. It acts as NK2 receptor antagonist. It is currently under development as a novel antidepressant by Sanofi-Aventis with a much different mechanism of action than any currently available antidepressants. As of yet, it has made it to phase III clinical trials.

On May 2009, Sanofi-Aventis published his quarterly results and announced the cessation of 14 projects of research-development, among which was Saredutant in phase III clinical trials, in the treatment of depression[1].

References

  1. ^ http://www.sanofi-aventis.com/binaries/Lettre18_FR_Web_acc_tcm29-25341.pdf Letter to the stockholders of Sanofi-Aventis on May 2009
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message